Filter posts

Exploring New Solutions For Neglected Diseases in Developing Countries

On Tuesday, BIO Ventures for Global Health (BVGH) announced the completion of the 30th research agreement …

CTTI: Use of Central IRBs in Multi-Center Trials to Streamline Clinical Research

Multi-center clinical trials can provide high-quality, statistically-sound evidence to answer medical questions. Earlier this year, …

New PhRMA Report: Nearly 300 Vaccines Currently in Development

Today, the Pharmaceutical Research and Manufacturers of America released a report, Medicines in Development: Vaccines …

NCATS R&D Day Aimed At Linking Investors to Preclinical Drug Development Projects

On behalf of the National Center for Advancing Translational Sciences (NCATS), I invite BIO stakeholders …

New FDA Final Guidance on Clinical Trial Institutional Review Boards

On Tuesday, August 27th, the FDA finalized its Guidance for Institutional Review Boards, Clinical Investigators …

The Dangers of Being Misinformed: Latest Measles Outbreak

USA Today covered the latest measles outbreak in today’s print edition (see story: Texas Measles …

Involving Patients in the Research Process

According to the National Psoriasis Foundation, as many as 7.5 million Americans live with psoriasis, …

GAINing Ground in Antibiotics

With the rise of antibiotic resistant “superbugs” in recent years, everyone agrees there is an …

FDA Issues Final Guidance on Clinical Trial Oversight

The FDA released its final guidance governing clinical trial oversight and urges a risk-based approach …

Back to School: Time for Immunization Check-In

Preparing for school means gathering supplies and backpacks. It is also the perfect time to …